• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估国家综合癌症网络的困境管理工具(v. 2.2018)在波哥大国家癌症研究所就诊患者中的使用情况。

Assessment of the operational characteristics of the National Comprehensive Cancer Network distress management tool, v. 2.2018, in patients seen at the Instituto Nacional de Cancerología, Bogotá.

机构信息

Grupo Área de Investigaciones, Instituto Nacional de Cancerología - E.S.E., Bogotá, D.C., Colombia; Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia.

Grupo de Salud Mental, Instituto Nacional de Cancerología - E.S.E., Bogotá, D.C., Colombia.

出版信息

Biomedica. 2021 Dec 15;41(4):721-733. doi: 10.7705/biomedica.6131.

DOI:10.7705/biomedica.6131
PMID:34936256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8759526/
Abstract

Introduction: Cancer patients have significant levels of emotional distress. The National Comprehensive Cancer Network (NCCN) developed the distress management tool to quickly assess significant distress in oncological patients who require intervention. For its use in Colombia, we made its cross-cultural adaptation and validation. Objective: To determine the operative characteristics of the distress management tool, version 2.2018, in patients seen at the Instituto Nacional de Cancerología (INC) in Colombia. Materials and methods: Counting with the authorization from the NCCN, we translated, made the cross-cultural adaptation, and evaluated the operational characteristics of the tool. We included 343 cancer patients seen at the INC, who filled out the cross-culturally adapted instrument. A diagnostic test study was carried out with a semi-structured interview as a reference. Results: The patients had an average age of 49.7 years (SD=15) and the majority were women (67%). The instrument had an area under the ROC curve of 0.81 (95% CI: 0.77 -0.86); its optimal cut-off point was 3.5 approached to 4 when using integers on the scale; its sensitivity was 0.81 (95% CI: 0.76 - 0.85), and its specificity, 0.69 (95% CI: 0.64 - 0.74). The agreement percentage between the result of the interview and the instrument was 73% (kappa = 0.64; p< 0.001). Conclusions: The distress management tool allowed for the detection of moderate to severe distress requiring intervention and management. This instrument was adapted and validated in cancer patients in Colombia keeping the cutoff point at ≥ 4 as in the original version.

摘要

简介

癌症患者存在明显的情绪困扰。美国国家综合癌症网络(NCCN)开发了这种痛苦管理工具,以便快速评估需要干预的肿瘤患者的显著痛苦。为了在哥伦比亚使用,我们对其进行了跨文化适应性和验证。目的:确定 NCCN 授权的 2.2018 版痛苦管理工具在哥伦比亚国家癌症研究所(INC)就诊的患者中的操作特性。材料和方法:在获得 NCCN 授权的情况下,我们对该工具进行了翻译、跨文化适应性调整,并评估了其操作特性。我们纳入了在 INC 就诊的 343 例癌症患者,他们填写了跨文化适应性工具。采用半结构化访谈作为参考进行诊断测试研究。结果:患者的平均年龄为 49.7 岁(标准差=15),大多数为女性(67%)。该工具的 ROC 曲线下面积为 0.81(95%置信区间:0.77-0.86);其最佳截断点为 3.5,接近整数尺度上的 4 时,接近 4;其灵敏度为 0.81(95%置信区间:0.76-0.85),特异性为 0.69(95%置信区间:0.64-0.74)。访谈结果与工具结果之间的一致性百分比为 73%(kappa=0.64;p<0.001)。结论:痛苦管理工具可检测需要干预和管理的中重度痛苦。该工具在哥伦比亚的癌症患者中进行了适应性和验证,保留了与原始版本相同的≥4 的截断点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/8759526/1fc653511b5b/2590-7379-bio-41-04-6131-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/8759526/1fc653511b5b/2590-7379-bio-41-04-6131-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768a/8759526/1fc653511b5b/2590-7379-bio-41-04-6131-gf1.jpg

相似文献

1
Assessment of the operational characteristics of the National Comprehensive Cancer Network distress management tool, v. 2.2018, in patients seen at the Instituto Nacional de Cancerología, Bogotá.评估国家综合癌症网络的困境管理工具(v. 2.2018)在波哥大国家癌症研究所就诊患者中的使用情况。
Biomedica. 2021 Dec 15;41(4):721-733. doi: 10.7705/biomedica.6131.
2
Breast and cervical cancer survival at Instituto Nacional de Cancerología, Colombia.哥伦比亚国立癌症研究所的乳腺癌和宫颈癌生存率。
Colomb Med (Cali). 2018 Mar 30;49(1):102-108. doi: 10.25100/cm.v49i1.2840.
3
[Cancer of the cervix uteri in the Instituto Nacional de Cancerología de Bogotá (Colombia)].[哥伦比亚波哥大国家癌症研究所的子宫颈癌]
Prensa Med Argent. 1965 Apr 9;52(11):601-4.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
[Frequency of gastric lymphoma at 6 hospitals in Mexico City].[墨西哥城6家医院胃淋巴瘤的发病率]
Rev Gastroenterol Mex. 2001 Apr-Jun;66(2):96-100.
6
Cross-cultural validation of the Child Adolescent Teasing Scale for Colombian students.《儿童青少年取笑量表》在哥伦比亚学生中的跨文化效度验证
Rev Lat Am Enfermagem. 2018;26:e2968. doi: 10.1590/1518-8345.2099.2968. Epub 2018 May 17.
7
[Clinical and microbiological characteristics of neutropenic enterocolitis in adults with blood cancer in the National Cancer Institute of Bogota D.C. (Colombia)].[哥伦比亚波哥大特区国立癌症研究所成年血癌患者中性粒细胞减少性小肠结肠炎的临床和微生物学特征]
Enferm Infecc Microbiol Clin. 2004 Oct;22(8):462-6. doi: 10.1157/13066853.
8
[Validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) in Colombia].[蒙哥马利-奥斯伯格抑郁评定量表(MADRS)在哥伦比亚的验证]
Rev Colomb Psiquiatr. 2016 Jul-Sep;45(3):146-55. doi: 10.1016/j.rcp.2015.08.006. Epub 2015 Oct 9.
9
A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia.非放射性聚合酶链反应-单链构象多态性分析能够区分哥伦比亚子宫颈鳞状细胞癌中HPV 16欧洲亚型和亚美尼亚亚型。
Virus Genes. 2008 Aug;37(1):22-30. doi: 10.1007/s11262-008-0239-8. Epub 2008 May 30.
10
Experience with the BIOMED-2 standardized polymerase chain reaction protocol for immunoglobulin and T- cell receptor clonality analysis in the Instituto Nacional de Cancerología, Colombia.在哥伦比亚国家癌症研究所使用 BIOMED-2 标准化聚合酶链反应方案进行免疫球蛋白和 T 细胞受体克隆性分析的经验。
Biomedica. 2022 May 1;42(Sp. 1):64-78. doi: 10.7705/biomedica.5940.

本文引用的文献

1
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.《 distress management 》,版本 3.2019, NCCN 肿瘤临床实践指南。
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249. doi: 10.6004/jnccn.2019.0048.
2
The Distress Thermometer: Cutoff Points and Clinical Use.痛苦温度计:临界值与临床应用。
Oncol Nurs Forum. 2017 May 1;44(3):329-336. doi: 10.1188/17.ONF.329-336.
3
Validation of the distress thermometer worldwide: state of the science.全球痛苦温度计的验证:科学现状。
Psychooncology. 2014 Mar;23(3):241-50. doi: 10.1002/pon.3430. Epub 2013 Nov 11.
4
Co-morbid mental health conditions in cancer patients at working age--prevalence, risk profiles, and care uptake.工作年龄癌症患者的共病心理健康状况——患病率、风险概况及医疗服务利用情况
Psychooncology. 2013 Oct;22(10):2291-7. doi: 10.1002/pon.3282. Epub 2013 Mar 14.
5
The Distress Thermometer and its validity: a first psychometric study in Indonesian women with breast cancer. distress thermometer 及其有效性:在印度尼西亚乳腺癌女性中的首次心理测量学研究。
PLoS One. 2013;8(2):e56353. doi: 10.1371/journal.pone.0056353. Epub 2013 Feb 13.
6
Distress management.痛苦管理。
J Natl Compr Canc Netw. 2013 Feb 1;11(2):190-209. doi: 10.6004/jnccn.2013.0027.
7
Integrating psychosocial care into cancer services.将心理社会关怀融入癌症服务中。
J Clin Oncol. 2012 Apr 10;30(11):1178-86. doi: 10.1200/JCO.2011.39.7398. Epub 2012 Mar 12.
8
What do 1281 distress screeners tell us about cancer patients in a community cancer center?1281 名 distress 筛查者能告诉我们社区癌症中心的癌症患者什么信息?
Psychooncology. 2011 Jun;20(6):594-600. doi: 10.1002/pon.1907. Epub 2011 Feb 8.
9
Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.健康相关生活质量测量在癌症临床试验中的附加值:NCIC CTG 的经验。
Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):119-28. doi: 10.1586/erp.10.15.
10
Screening for emotional distress in cancer patients: a systematic review of assessment instruments.癌症患者情绪困扰的筛查:评估工具的系统综述
J Natl Cancer Inst. 2009 Nov 4;101(21):1464-88. doi: 10.1093/jnci/djp336. Epub 2009 Oct 13.